Search Within

Ashley A Foster

Formats
  1. Meeting Abstract (4)
  2. Journal Article (1)
Groups
  1. Department of Medicine (5)
  2. Genitourinary Oncology Service (5)
  3. Solid Tumor Oncology Division (5)
  4. Weinberg Fellows (5)
  5. Human Oncology and Pathogenesis Program (4)
  6. Biostatistics Service (3)

More Groups

People
  1. Martin Voss (5)
  2. Robert Motzer (5)
  3. Abraham Hakimi (3)
  4. Chung-Han Lee (3)
  5. Darren Feldman (3)
  6. Joshua Chaim (3)

More People

Years
  1. 2020 (3)
  2. 2019 (2)
Publications
  1. Journal of Clinical Oncology (3)
  2. Journal for ImmunoTherapy of Cancer (1)
  3. Journal of Molecular Diagnostics (1)
Publishers
  1. American Society of Clinical Oncology (3)
  2. Biomed Central Ltd (1)
  3. Elsevier Science, Inc. (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Noninvasive genomic profiling of 113 patients with advanced renal cell carcinoma
    Meeting Abstract

    Gedvilaite, E.; Kotecha, R.; Murray, S.; Foster, A.; Motzer, R.; Ptashkin, R.; Johnson, I.; Shah, R.; Dunigan, M.; Huberman, K.; more...
    Journal of Molecular Diagnostics (2020)

    Fulltext@MSK | Save
  • DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy
    Journal Article

    Ged, Y.; Chaim, J. L.; DiNatale, R. G.; Knezevic, A.; Kotecha, R. R.; Carlo, M. I.; Lee, C. H.; Foster, A.; Feldman, D. R.; Teo, M. Y.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Comparative circulating tumor DNA (ctD-NA) genomic profiling in 110 patients with advanced renal cell carcinoma
    Meeting Abstract

    Kotecha, R.; Gedvilaite, E.; Murray, S. J.; Foster, A.; Motzer, R. J.; Tsui, D.; Voss, M. H.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Association of body mass index (BMI) with clinical outcomes in 203 metastatic clear cell renal cell carcinoma (ccRCC) patients (pts) treated with immuno-oncology (IO) agents
    Meeting Abstract

    Ged, Y.; Lee, C. H.; Sanchez, A.; Duzgol, C.; Chaim, J.; Carlo, M. I.; Foster, A.; Akin, O.; Feldman, D. R.; Hakimi, A. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Alterations in DNA damage repair (DDR) genes and outcomes to systemic therapy in 225 immune-oncology (10) versus tyrosine kinase inhibitor (TKI) treated metastatic clear cell renal cell carcinoma (mccRCC) patients (pts)
    Meeting Abstract

    Ged, Y.; Chaim, J.; Knezevic, A.; Carlo, M. I.; Foster, A.; Feldman, D. R.; Teo, M. Y.; Riaz, N.; Lee, C. H.; Patil, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save